Search Results - "Ciresi, A"

Refine Results
  1. 1

    Vitamin D across growth hormone (GH) disorders: From GH deficiency to GH excess by Ciresi, A, Giordano, C

    Published in Growth hormone & IGF research (01-04-2017)
    “…Abstract The interplay between vitamin D and the growth hormone (GH)/insulin-like growth factor (IGF)-I system is very complex and to date it is not fully…”
    Get full text
    Journal Article
  2. 2

    Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance by Amato, M. C., Vesco, R., Vigneri, E., Ciresi, A., Giordano, C.

    Published in Journal of endocrinological investigation (01-12-2015)
    “…Purpose Insulin resistance and compensatory hyperinsulinism are the predominant metabolic defects in polycystic ovary syndrome (PCOS). However,…”
    Get full text
    Journal Article
  3. 3

    One-hour post-load plasma glucose level is associated with a worse metabolic profile in children with GH deficiency by Ciresi, A., Giordano, C.

    Published in Journal of endocrinological investigation (01-07-2018)
    “…Purpose In children, the plasma glucose value at 1 h (1hPG) during OGTT higher than 132.5 mg/dl is a predictor of alterations in glucose metabolism. We aimed…”
    Get full text
    Journal Article
  4. 4

    Insulin sensitivity and secretion and adipokine profile in patients with Cushing’s disease treated with pasireotide by Guarnotta, V., Pizzolanti, G., Ciresi, A., Giordano, C.

    Published in Journal of endocrinological investigation (01-10-2018)
    “…Purpose To evaluate the effect of pasireotide on β-cell and adipose function in patients with Cushing’s disease (CD). Methods Clinical and hormonal parameters,…”
    Get full text
    Journal Article
  5. 5

    Visceral Adiposity Index Is Associated with Insulin Sensitivity and Adipocytokine Levels in Newly Diagnosed Acromegalic Patients by Ciresi, A, Amato, M. C, Pizzolanti, G, Giordano Galluzzo, C

    “…Context: The visceral adiposity index (VAI) has proved to be a marker of visceral adipose dysfunction, strongly associated with insulin sensitivity in both the…”
    Get full text
    Journal Article
  6. 6

    Dual-release hydrocortisone vs conventional glucocorticoids in adrenal insufficiency by Guarnotta, V, Di Stefano, C, Santoro, A, Ciresi, A, Coppola, A, Giordano, C

    Published in Endocrine Connections (01-07-2019)
    “…Background Dual-release hydrocortisone (DR-HC) improves metabolism in patients with adrenal insufficiency. The aims of this study were to compare the…”
    Get full text
    Journal Article
  7. 7

    Reduction in insulin sensitivity and inadequate β-cell capacity to counteract the increase in insulin resistance in children with idiopathic growth hormone deficiency during 12 months of growth hormone treatment by Ciresi, A., Amato, M. C., Giordano, C.

    Published in Journal of endocrinological investigation (01-03-2015)
    “…Purpose To evaluate the performance of various indexes of insulin sensitivity and secretion and to identify the most useful indicator of deterioration of…”
    Get full text
    Journal Article
  8. 8

    High prevalence of hypovitaminosis D in Sicilian children affected by growth hormone deficiency and its improvement after 12 months of replacement treatment by Ciresi, A., Cicciò, F., Giordano, C.

    Published in Journal of endocrinological investigation (01-07-2014)
    “…Purpose Although the correlation between vitamin D and growth hormone (GH)-insulin-like growth factor 1 (IGF1) axis is documented, as of date, few and…”
    Get full text
    Journal Article
  9. 9

    Efficacy of combined treatment with pasireotide, pegvisomant and cabergoline in an acromegalic patient resistant to other treatments: a case report by Ciresi, A, Radellini, S, Guarnotta, V, Giordano, C

    Published in BMC endocrine disorders (24-01-2018)
    “…The approach to acromegalic patients with persistent acromegaly after surgery and inadequate response to first-generation somatostatin receptor ligands (SRLs)…”
    Get full text
    Journal Article
  10. 10

    The Metabolic Profile in Active Acromegaly is Gender-Specific by Ciresi, A, Amato, M. C, Pivonello, R, Nazzari, E, Grasso, L. F, Minuto, F, Ferone, D, Colao, A, Giordano, C

    “…Context: The sexual dimorphism of the somatotroph axis has been documented, but whether the acromegaly-related metabolic alterations are gender-dependent has…”
    Get full text
    Journal Article
  11. 11

    No Phenotypic Differences for Polycystic Ovary Syndrome (PCOS) Between Women With and Without Type 1 Diabetes Mellitus by Amato, M. C, Guarnotta, V, Ciresi, A, Modica, R, Pantò, F, Giordano, C

    “…Context: Women with type 1 diabetes mellitus (DM1) have a higher prevalence of polycystic ovary syndrome (PCOS) than the general population. Objective: The aim…”
    Get full text
    Journal Article
  12. 12

    Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children by Ciresi, A., Pizzolanti, G., Leotta, M., Guarnotta, V., Teresi, G., Giordano, C.

    Published in Journal of endocrinological investigation (01-09-2016)
    “…Purpose The effect of growth hormone (GH) on adipose tissue and the role of adipokines in modulating metabolism are documented, but with discordant data. Our…”
    Get full text
    Journal Article
  13. 13

    Revaluation of the clinical and metabolic behavior of children with isolated growth hormone deficiency during GH treatment according to newly proposed note 39 of the Italian Medicines Agency (AIFA) by Ciresi, A., Cicciò, F., Amato, M. C., Giordano, C.

    Published in Journal of endocrinological investigation (01-12-2015)
    “…Purpose This study aimed at evaluating the clinical and metabolic behavior of children with isolated growth hormone (GH)-deficiency (GHD), grouped according to…”
    Get full text
    Journal Article
  14. 14

    Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study by Albani, A., Ferraù, F., Ciresi, A., Pivonello, R., Scaroni, C., Iacuaniello, D., Zilio, M., Guarnotta, V., Alibrandi, A., Messina, E., Boscaro, M., Giordano, C., Colao, A., Cannavo, S.

    Published in Endocrine (01-07-2018)
    “…Purpose Patients with Cushing’s disease (CD) experience metabolic alterations leading to increased cardiovascular mortality. Recently, the visceral adiposity…”
    Get full text
    Journal Article
  15. 15

    Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations by Ciresi, A, Amato, M.C, Pizzolanti, G, Giordano, C

    Published in Growth hormone & IGF research (01-10-2015)
    “…Abstract Objective The studies that have extensively evaluated the relation between adipokines and metabolic parameters in acromegaly treatment are quite…”
    Get full text
    Journal Article
  16. 16

    Correlation between adrenal function, growth hormone secretion, and insulin sensitivity in children with idiopathic growth hormone deficiency by Ciresi, A., Radellini, S., Vigneri, E., Guarnotta, V., Bianco, J., Mineo, M. G., Giordano, C.

    Published in Journal of endocrinological investigation (01-03-2018)
    “…Purpose Patients with growth hormone deficiency (GHD) demonstrate an increased cortisol/cortisone ratio which could potentially explain the metabolic features…”
    Get full text
    Journal Article
  17. 17

    Corneal thickness in children with growth hormone deficiency: The effect of GH treatment by Ciresi, A, Morreale, R, Radellini, S, Cillino, S, Giordano, C

    Published in Growth hormone & IGF research (01-08-2014)
    “…Abstract Objective The eye represents a target site for GH action, although few data are available in patients with GH deficiency (GHD). Our aim was to…”
    Get full text
    Journal Article
  18. 18

    Correlation between severity of growth hormone deficiency and thyroid metabolism and effects of long-term growth hormone treatment on thyroid function in children with idiopathic growth hormone deficiency by Ciresi, A, Guarnotta, V, Amato, M C, Giordano, C

    Published in Hormone research in paediatrics (01-01-2014)
    “…The significance of changes in thyroid function in children during growth hormone (GH) treatment remains uncertain. We aimed to evaluate the impact of GH…”
    Get more information
    Journal Article
  19. 19

    Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency by Ciresi, A, Amato, M C, Criscimanna, A, Mattina, A, Vetro, C, Galluzzo, A, D’Acquisto, G, Giordano, C

    Published in European journal of endocrinology (01-03-2007)
    “…Objective: GH replacement therapy in children with GH deficiency (GHD) mainly promotes linear growth. Not only have very few studies fully analyzed the…”
    Get full text
    Journal Article
  20. 20

    Early Lung Function Abnormalities in Acromegaly by Benfante, A., Ciresi, A., Bellia, M., Cannizzaro, F., Bellia, V., Giordano, C., Scichilone, N.

    Published in Lung (01-06-2015)
    “…Background Acromegaly is an insidious disorder caused by a pituitary growth hormone (GH)-secreting adenoma resulting in high circulating levels of GH and…”
    Get full text
    Journal Article